iPRIME-CS

iPRIME Clinician Scientist Program

The Else Kröner-Fresenius-Stiftung – Clinician Scientist program was awarded in 2021 to the iPRIME-CS program headed by Tobias B. Huber and Ulf Panzer from the HCKH. iPRIME-CS connects our doctoral curriculum iPRIME (awarded by the EKFS and headed by Tobias B. Huber and Ulf Panzer) and the Advanced Clinician Scientist program iSTAR (awarded by the BMBF in 2021, headed by Samuel Huber, Marylyn Addo and Tobias B. Huber) complementing a truly unique medical clinician-scientist educational path.

iPRIME-CS provides an individualized clinician-scientist curriculum and infrastructure for scientifically and clinically highly motivated doctors at the beginning of their specialist training. The program provides a sustainable iPRIME-CS career plan up to medical specialist (6 years), including 24 month of protected research time, integration into a working group of HCKH team leaders and the development of an independent scientific profile.

Visit iPRIME-CS

Read more …iPRIME-CS

HERO

The Hamburg and European Renal Omics-Biobank

The Hamburg and European Renal Omics-Biobank (HERO) provides a unique source of longitudinal clinical data and diverse biospecimens from adults and children with a broad spectrum of kidney diseases. In addition to comprehensive clinical phenotyping of patients, HERO focuses on single cell and OMICS analyses to identify critical cells, signaling pathways, and targets for new therapies to gain a better understanding of kidney diseases and their pathogenesis, in order to refine diagnoses and prognoses and provide individualized and optimized treatment to patients in the future.

For further information, please contact:
Maja Lindenmeyer (Coordinator), This email address is being protected from spambots. You need JavaScript enabled to view it. or
Sydney Gies (Deputy Coordinator), This email address is being protected from spambots. You need JavaScript enabled to view it.

Read more …HERO

Research unit 5211

Research unit 5211

SOMACROSS - Persistent SOMAtic Symptoms ACROSS Diseases: From Risk Factors to Modification

The goal of the interdisciplinary Research Unit (RU) SOMACROSS is to determine the complex and dynamic biopsychosocial interplay in the transition from acute to persistent symptom states, i.e., to investigate which factors and mechanisms contribute to the persistence of somatic symptoms over time. Hence, we will examine biological, psychological, and social factors that are expected to contribute to the persistence of somatic symptoms in a number of different syndromes and diseases by conducting eight projects based on a common working model. All projects use prospective designs, harmonised measurement times, joint core measures and coordinated evaluation methods, which allows both project-specific and cross-project evaluation. With the newly achieved insights into the multifactorial development of persistent somatic symptoms, we will be able to develop scientifically sound approaches to modify these symptoms and thereby provide targeted help to patients in the future.

Visit www.uke.de

Read more …Research unit 5211

Research Networks

Research Networks

Save the kidney

Nordverbund Niere

The Förderverein Nordverbund Niere- Save the Kidney e. V. is a cross-location association of renowned scientists and renal physicians from Greifswald, Hamburg, Hannover, Kiel and Rostock for goal-oriented research on the kidney.

Visit www.savethekidney.de

ERKNet

The European Rare Kidney Disease Reference Network

ERKNet is the European Reference Network for Rare Kidney Diseases, a consortium of 72 nephrology centers of expertise for children and adults in 24 European countries, serving more than 70.000 patients with rare kidney diseases.

Visit www.erknet.org

NEPHCURE

Kidney International

NephCure Kidney International’s mission is to accelerate research for effective treatments for rare forms of Nephrotic Syndrome, and to provide education and support that will improve the lives of those affected by these protein-spilling kidney diseases.

Visit www.nephcure.org

neptune

Nephrotic Syndrome Study Network

Neptune is a research consortium of physician scientists at 26 sites in the United States and Canada. NEPTUNE strives to bring the latest advances in research to patients diagnosed with Focal Segmental Glomerulosclerosis (FSGS), Minimal Changes Disease (MCD), and Membranous Nephropathy (MN) with an overarching goal of utilizing precision medicine for rare diseases.

Visit www.neptune-study.org

ISGD

International Society of Glomerular Disease

ISGD is led by an international collective of experts in glomerular disease science and clinical care. In keeping with our ethos of cross-stakeholder collaboration, our steering committee includes not only practicing physicians and researchers, but also representation from allied professional societies, patient organizations, and industry.

Practice areas and specializations on the team include nephrology, pediatric nephrology, renal pathology, immunology, and genetics, as well as clinical, translational, and basic research.

Visit www.is-gd.org

KPMP

Kidney Precision Medicine Project

The KPMP is a multi-year collaboration of leading research institutions to study patients with kidney disease.

Visit www.kpmp.org

Read more …Research Networks

Martinistraße 52
Campus Research II N25
20246 Hamburg Germany
This email address is being protected from spambots. You need JavaScript enabled to view it.

University Medical Center Hamburg - Eppendorf